Isis Pharmaceuticals Inc (NASDAQ:ISIS)

34.01
Data as of Apr 17
 -0.56 / -1.62%
Today’s Change
18.27
Today|||52-Week Range
62.66
-14.63%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$4.2B

Company Description

Isis Pharmaceuticals, Inc. engages in the development and commercialization of drugs to treat various health conditions, including inflammatory, viral, metabolic and cardiovascular and dermatological diseases and cancer. The company operates in two segments: Drug Discovery & Development and Regulus. The Drug Discovery & Development segment exploits a novel drug discovery platform created to generate a broad pipeline of first-in-class drugs for the company and for its partners. The Regulus segment focuses on developing microRNA-targeted therapeutics in cancer, fibrosis, metabolic disorders and inflammatory disorders. Isis Pharmaceuticals was founded by Stanley T. Crooke in January 1989 and is headquartered in Carlsbad, CA.

Contact Information

Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad California 92010
P:(760) 931-9200
Investor Relations:
(760) 603-2772

Employees

Shareholders

Mutual fund holders66.71%
Individual stakeholders6.98%
Other institutional22.54%

Top Executives

Stanley T. CrookeChairman, President & Chief Executive Officer
B. Lynne ParshallChief Operating Officer, Secretary & Director
Elizabeth L. HougenChief Financial Officer & Senior Vice President
C. Frank BennettSenior Vice President-Research
Brett P. MoniaSenior VP-Drug Discovery & Corporate Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.